FRMS CO., LTD(SZ:300049) Xin Lang Cai Jing·2025-10-17 01:30Core Viewpoint - The financial performance and trading activity of Furuya Co., Ltd. indicate a mixed outlook, with a slight decline in stock price and fluctuating financing activities, while the company continues to show growth in revenue but a significant drop in net profit [1][2]. Financing Activity - On October 16, Furuya Co., Ltd. experienced a financing buy-in of 43.17 million yuan, with a net financing outflow of 0.2851 million yuan, resulting in a total financing balance of 1.199 billion yuan, which accounts for 6.86% of the circulating market value [1]. - The financing balance is above the 90th percentile level over the past year, indicating a high level of financing activity [1]. - In terms of securities lending, the company had a lending balance of 0.873 million yuan, which is below the 10th percentile level over the past year, suggesting low borrowing activity [1]. Financial Performance - For the first half of 2025, Furuya Co., Ltd. reported a revenue of 713 million yuan, reflecting a year-on-year growth of 11.02%, while the net profit attributable to shareholders decreased by 31.09% to 51.934 million yuan [2]. - Cumulatively, the company has distributed 246 million yuan in dividends since its A-share listing, with 52.6106 million yuan distributed over the past three years [3]. Shareholder Structure - As of September 20, the number of shareholders for Furuya Co., Ltd. decreased by 5.41% to 25,900, while the average circulating shares per person increased by 5.72% to 9,020 shares [2]. - The top ten circulating shareholders include notable institutional investors, with Hua Bao Zhong Zheng Medical ETF increasing its holdings by 947,800 shares, while Rui Yuan Growth Value Mixed A reduced its holdings by 128,300 shares [3].